Showing results (101-110 of 139) with videos related to
Sort By:
Pageof 14
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 30, 2022
SOCRATE-PRODIGE 55 trial: A randomized phase II study to evaluate second-line ramucirumab alone or with paclitaxel in older patients with advanced gastric cancerEmeric Boisteau, Eric François, Thomas Aparicio, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 19, 2008
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximabAstrid Lièvre, Jean-Baptiste Bachet, Valérie Boige, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2014
Molecular testing for lymph node metastases as a determinant of colon cancer recurrence: results from a retrospective multicenter studyDaniel J Sargent, Qian Shi, Sharlene Gill, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 4, 2025
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece TrialsJulien Taieb, John Souglakos, Ioannis Boukovinas, et al.International Journal of Oncology|February 6, 2019
Efficacy of aflibercept with FOLFOX and maintenance with fluoropyrimidine as first‑line therapy for metastatic colorectal cancer: GERCOR VELVET phase II studyBenoist Chibaudel, Jean-Baptiste Bachet, Thierry André, et al.The Lancet. Oncology|October 18, 2015
Bevacizumab with or without erlotinib as maintenance therapy in patients with metastatic colorectal cancer (GERCOR DREAM; OPTIMOX3): a randomised, open-label, phase 3 trialChristophe Tournigand, Benoist Chibaudel, Benoit Samson, et al.Bulletin Du Cancer|July 10, 2017
[Clinical research activity of the French cancer cooperative network: Overview and perspectives]Claire Dubois, Franck Morin, Denis Moro-Sibilot, et al.Bulletin Du Cancer|February 15, 2020
[Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]Romain Cohen, Thomas Pudlarz, Marie-Line Garcia-Larnicol, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 28, 2020
PRODIGE 59-DURIGAST trial: A randomised phase II study evaluating FOLFIRI + Durvalumab ± Tremelimumab in second-line of patients with advanced gastric cancerCamille Evrard, Christophe Louvet, Farid El Hajbi, et al.European Journal of Cancer (Oxford, England : 1990)|November 25, 2019
Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trialPascal Hammel, Portales Fabienne, Laurent Mineur, et al.Pageof 14